Publication | Open Access
SLIT3 promotes myogenic differentiation as a novel therapeutic factor against muscle loss
27
Citations
31
References
2021
Year
SLIT3 plays a sarcoprotective role by activating β-catenin signalling. SLIT3 LRRD2 can potentially be used as a therapeutic agent against muscle loss.
| Year | Citations | |
|---|---|---|
2018 | 13.1K | |
2001 | 598 | |
2003 | 515 | |
2004 | 384 | |
2018 | 349 | |
2013 | 289 | |
2013 | 275 | |
2018 | 164 | |
2007 | 161 | |
2011 | 160 |
Page 1
Page 1